SCHEMBL30159532

SCHEMBL30159532

COC(=O)c1ccc(=O)n(-c2ccc(F)c(F)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HSD17B10 Q99714 1/20 0.47
KDM4E B2RXH2 2/20 0.44
LMNA P02545 1/20 0.44
P2RX3 P56373 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 2/20 0.42
MET P08581 2/20 0.41
POLB P06746 1/20 0.41
THRB P10828 1/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
CASP3 P42574 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24849951 1.00 ALDH1A1 (0.47) ALDH1A1L3MBTL1HSD17B10KDM4ELMNA
SCHEMBL25078626 0.85 HSD17B10 (0.44) ALDH1A1L3MBTL1HSD17B10KDM4ELMNA
SCHEMBL2459873 0.84 KMT2A (0.52) ALDH1A1L3MBTL1HSD17B10KDM4ELMNA
SCHEMBL16503320 0.80 CA1 (0.58) ALDH1A1HSD17B10KDM4ELMNAP2RX3
SCHEMBL22229984 0.78 HSD17B10 (0.42) ALDH1A1L3MBTL1HSD17B10KDM4ELMNA
SCHEMBL16503321 0.78 ALDH1A1 (0.64) ALDH1A1HSD17B10KDM4ELMNAP2RX3
SCHEMBL142307 0.78 KDM4E (0.53) ALDH1A1L3MBTL1HSD17B10KDM4ELMNA
SCHEMBL1504529 0.77 ALDH1A1 (0.46) ALDH1A1L3MBTL1HSD17B10KDM4ELMNA
SCHEMBL25078533 0.76 ALDH1A1 (0.48) ALDH1A1L3MBTL1KDM4ELMNAHTT
SCHEMBL30949243 0.76 ALDH1A1 (0.48) ALDH1A1L3MBTL1KDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002346-A1 NEW COMPOUNDS AND METHODS BenevolentAl Bio Limited (GB) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002346-A1 NEW COMPOUNDS AND METHODS ABL2, ABL1, ALK ALDH1A1 651/4885L3MBTL1 2917/4885HSD17B10 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.